BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28695396)

  • 1. Active smoking and survival following breast cancer among African American and non-African American women in the Carolina Breast Cancer Study.
    Parada H; Sun X; Tse CK; Olshan AF; Troester MA; Conway K
    Cancer Causes Control; 2017 Sep; 28(9):929-938. PubMed ID: 28695396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study.
    Williams LA; Olshan AF; Tse CK; Bell ME; Troester MA
    Cancer Causes Control; 2016 Feb; 27(2):259-69. PubMed ID: 26705260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active smoking and risk of Luminal and Basal-like breast cancer subtypes in the Carolina Breast Cancer Study.
    Butler EN; Tse CK; Bell ME; Conway K; Olshan AF; Troester MA
    Cancer Causes Control; 2016 Jun; 27(6):775-86. PubMed ID: 27153846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers.
    Purrington KS; Gorski D; Simon MS; Hastert TA; Kim S; Rosati R; Schwartz AG; Ratnam M
    Breast Cancer Res Treat; 2020 May; 181(1):145-154. PubMed ID: 32236827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.
    O'Brien KM; Cole SR; Tse CK; Perou CM; Carey LA; Foulkes WD; Dressler LG; Geradts J; Millikan RC
    Clin Cancer Res; 2010 Dec; 16(24):6100-10. PubMed ID: 21169259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis.
    John EM; McGuire V; Kurian AW; Koo J; Shariff-Marco S; Gomez SL; Cheng I; Keegan THM; Kwan ML; Bernstein L; Vigen C; Wu AH
    Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):351-363. PubMed ID: 33355191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer death rates in lifelong nonsmokers.
    Thun MJ; Henley SJ; Burns D; Jemal A; Shanks TG; Calle EE
    J Natl Cancer Inst; 2006 May; 98(10):691-9. PubMed ID: 16705123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
    Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
    JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
    Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
    Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?
    Warner ET; Tamimi RM; Boggs DA; Rosner B; Rosenberg L; Colditz GA; Palmer JR
    Cancer Causes Control; 2013 Apr; 24(4):731-9. PubMed ID: 23380944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of dichlorodiphenyldichloroethene (DDE) and dichlorodiphenyltrichloroethane (DDT) and survival following breast cancer in the Carolina Breast Cancer Study.
    Parada H; Sun X; Tse CK; Engel LS; Olshan AF; Troester MA
    Environ Int; 2019 Apr; 125():161-171. PubMed ID: 30716576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y; West R; Weber JD; Colditz GA
    Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.
    Bertrand KA; Bethea TN; Rosenberg L; Bandera EV; Khoury T; Troester MA; Ambrosone CB; Palmer JR
    Breast; 2020 Feb; 49():108-114. PubMed ID: 31786415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of breast cancer risk factors among African-American women and White women.
    Hall IJ; Moorman PG; Millikan RC; Newman B
    Am J Epidemiol; 2005 Jan; 161(1):40-51. PubMed ID: 15615914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of breast cancer treatment delay differ for African American and White women.
    McGee SA; Durham DD; Tse CK; Millikan RC
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1227-38. PubMed ID: 23825306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control analysis of smoking and breast cancer in African American women: findings from the AMBER Consortium.
    Park SY; Palmer JR; Rosenberg L; Haiman CA; Bandera EV; Bethea TN; Troester MA; Viscidi E; Kolonel LN; Olshan AF; Ambrosone CB
    Carcinogenesis; 2016 Jun; 37(6):607-15. PubMed ID: 27207658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
    Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
    Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race and the prognostic influence of p53 in women with breast cancer.
    Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
    Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.